Joint modeling of multivariate longitudinal data and the dropout process in a competing risk setting: Application to ICU data

BMC Medical Research Methodology

Volumn 10, Issue , 2010, Pages

  Deslandes, Emmanuelle ^a,b,c   Chevret, Sylvie ^a,b,c  

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; COMPUTER SIMULATION; HUMAN; INTENSIVE CARE UNIT; LONGITUDINAL STUDY; METHODOLOGY; MONTE CARLO METHOD; MULTIVARIATE ANALYSIS; PROBABILITY; PROPORTIONAL HAZARDS MODEL; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICS; SURVIVAL;

ALGORITHMS; COMPUTER SIMULATION; HUMANS; INTENSIVE CARE UNITS; LONGITUDINAL STUDIES; MARKOV CHAINS; MONTE CARLO METHOD; MULTIVARIATE ANALYSIS; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 77954986665     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-10-69     Document Type: Article

References (57)

1. APACHE - acute physiology andchronic health evaluation: a physiologically based classification system. W Knaus J Zimmerman D Wagner E Draper D Lawrence, Crit Care Med 1981 9 591 7 10.1097/00003246-198108000-00008 7261642
2. Prognostic factors in severe head injury. R Davis P Cunningham, Surg Gynecol & Obstet 1984 159 6 597 604
3. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on sepsisrelated problems of the European Society of Intensive Care Medicine. J Vincent A DeMendonca F Cantraine R Moreno J Takala P Suter C Sprung, Crit Care Med 1998 26 1793 1800 9824069
4. Quantifying Risk and Benchmarking Performance in the Adult Intensive Care Unit. TL Higgins, J Intensive Care Med 2007 22 3 141 56 10.1177/ 0885066607299520 17562738
5. Application of the sequential organ failure assessment score to cardiac surgical patients. R Ceriani M Mazzoni F Bortone S Gandini C Solinas G Susini O Parodi, Chest 2003 123 4 1229 39 10.1378/chest.123.4.1229 12684316
6. Effects of N-Acetylcysteineon Microalbuminuria and Organ Failure in Acute Severe Sepsis: Results of a Pilot Study. HD Spapen MW Diltoer DN Nguyen I Hendrickx LP Huyghens, Chest 2005 127 4 1413 9 10.1378/chest.127.4.1413 15821223
7. Effect of a Liberal Versus Restrictive Transfusion Strategy on Mortality in Patients with Moderate to Severe Head Injury. LA McIntyre DA Fergusson J Hutchison G Pagliarello M JC E Yetisir G Hare, Neurocrit Care 2006 5 4 9 10.1385/NCC:5:1:4 16960287
8. Safety and Efficacy of Intensive Insulin Therapy in Critical Neurosurgical Patients. F Bilotta R Caramia FP Paoloni R Delfini G Rosa, Anesthesiology 2009 110 3 611 19 10.1097/ALN.0b013e318198004b 19237874
9. Analysing changes in the presence of informative right censoring caused by death and withdrawal. MC Wu K Bailey, Stat Med 1988 7 1-2 337 46 10.1002/sim.4780070134 3281208
10. Estimation and Comparison of Changes in the Presence of Informative Right Censoring by Modelling the Censoring Process. M Wu R Caroll, Biometrics 1988 44 175 188 10.2307/2531905 (Pubitemid 18098821)
11. Model-based approaches to analysing incomplete longitudinal and failure time data. JW Hogan NM Laird, Stat Med 1997 16 1-3 259 72 10.1002/(SICI)1097- 0258(19970215)16:3<259::AID-SIM484>3.0.CO;2-S 9004396
12. Joint modeling of longitudinal and time-to-event data: An overview. A Tsiatis M Davidian, Statist Sinica 2004 14 809 834 (Pubitemid 39499214)
13. Modeling the relationship of survival to Longitudinal Data Measured with Error. Applications to Survival and CD4 Counts in Patients with AIDS. A Tsiatis V De Gruttola M Wulfsohn, JASA 1995 90 429 27 37
14. Simultaneously modelling censored survival data and repeatedly measured covariates: a Gibbs sampling approach. CL Faucett DC Thomas, Stat Med 1996 15 15 1663 85 10.1002/(SICI)1097-0258(19960815)15:15<1663::AID-SIM294>3.0.CO;2- 1 8858789
15. Joint modelling of longitudinal measurements and event time data. R Henderson P Diggle A Dobson, Biostatistics 2000 1 4 465 80 10.1093/ biostatistics/1.4.465 12933568
16. An estimator for the proportionnal hazards model with multiple longitudinal covariates measured with error. X Song M Davidian A Tsiatis, Biostatistics 2002 3 4 511 528 10.1093/biostatistics/3.4.511 12933595
17. A comparison of two methods for the estimation of precision with incomplete longitudinal data, jointly modelled with a time-to-event outcome. G Touloumi AG Babiker MG Kenward SJ Pocock JH Darbyshire, Stat Med 2003 22 20 3161 75 10.1002/sim.1547 14518021
18. Joint modeling of quantitative longitudinal data and censored survival time. H Jacqmin-Gadda R Thiebaut JF Dartigues, RESP 2004 52 6 502 10
19. Joint modelling of bivariate longitudinal data with informative dropout and left-censoring, with application to the evolution of CD4+ cell count and HIV RNA viral load in response to treatment of HIV infection. R Thiebaut H Jacqmin-Gadda A Babiker D Commenges TC Collaboration, Stat Med 2005 24 65 82 10.1002/sim.1923 15523706
20. Joint modeling of survival and longitudinal data: likelihood approach revisited. F Hsieh YK Tseng JL Wang, Biometrics 2006 62 4 1037 43 10.1111/j.1541-0420.2006.00570.x 17156277
21. An approach to joint analysis of longitudinal measurements and competing risks failure time data. RM Elashoff G Li N Li, Stat Med 2007 26 14 2813 35 10.1002/sim.2749 17124698
22. Joint modelling of repeated measurements and time-to-event outcomes: the fourth Armitage lecture. P Diggle S I A Chetwynd, Stat Med 2008 27 16 2981 98 10.1002/sim.3131 18041047
23. Semiparametric modeling of longitudinal measurements and time-to-event data - a two stage regression calibration approach. W Ye X Lin J Taylor, Biometrics 2008 84 4 1238 46 10.1111/j.1541-0420.2007.00983.x
24. A semiparametric joint model for longitudinal and survival data with application to hemodialysis study. L Li B Hu T Greene, Biometrics 2009 65 3 737 45 10.1111/j.1541-0420.2008.01168.x 19173700
25. Joint modeling and analysis of longitudinal data with informative observation times. Y Liang W Lu Z Ying, Biometrics 2009 65 2 377 84 10.1111/j.1541-0420.2008.01104.x 18759841
26. Joint modeling longitudinal semi-continuous data and survival, with application to longitudinal medical cost data. L Liu, Stat Med 2009 28 6 972 86 10.1002/sim.3497 19040210
27. Robust joint modeling of longitudinal measurements and competing risks failure time data. N Li R Elashoff G Li, Biom J 2009 51 19 30 10.1002/bimj.200810491 19197956
28. Tutorial in biostatistics: competing risks and multi-state models. H Putter M Fiocco RB Geskus, Stat Med 2007 26 11 2389 430 10.1002/sim.2712 17031868
29. Evaluating mortality in intensive care units: contribution of competing risks analyses. M Resche-Rigon E Azoulay S Chevret, Crit Care 2006 10 R5 1 6
30. Risk Factors for the Development of Nosocomial Pneumonia and Mortality on Intensive Care Units: Application of Competing Risks Models. M Wolkewitz RP Vonberg H Grundmann J Beyersmann P Gastmeier S Barwolff C Geffers M Behnke H Ruden M Schumacher, Crit Care 2008 12 2 44 10.1186/cc6852 18384672
31. Joint models for multivariate longitudinal and multivariate survival data. YY Chi JG Ibrahim, Biometrics 2006 62 2 432 45 10.1111/j.1541-0420.2005. 00448.x 16918907
32. An approach to joint analysis of longitudinal measurements and competing risks failure time data. RM Elashoff G Li N Li, Biometrics 2008 64 3 762 71 10.1111/j.1541-0420.2007.00952.x 18162112
33. Joint Modelling of Longitudinal and Competing Risks Data. PR Williamson R Kolamunnage-Dona P Philipson AG Marson, Stat Med 2008 27 30 6426 6438 10.1002/sim.3451 18825652
34. A robust method for comparing two treatments in a confirmatory clinical trial via multivariate time-to-event methods that jointly incorporate information from longitudinal and time-to-event data. B Saville H AH G Koch, Stat Med 2009 29 75 85
35. Applying Cox regression to competing risks. M Lunn D McNeil, Biometrics 1995 51 2 524 32 10.2307/2532940 7662841
36. A proportionnal hazards model for the subdistribution of a competing risk. J Fine R Gray, JASA 1999 94 446 496 509
37. A Class of K-Sample tests for Comparing the Cumulative Incidence of a Competing Risk. R Gray, Ann Statist 1988 16 3 1141 1154 10.1214/aos/1176350951
38. A Bayesian approach to joint analysis of longitudinal measurements and competing risks failure time data. W Hu G Li N Li, Stat Med 2009 28 11 1601 19 10.1002/sim.3562 19308919
39. A program for smoothing scatterplots by robust locally weighted regression. WS Cleveland, Am Stat 1981 35 54
40. Dichotomizing continuous predictors in multiple regression: a bad idea. P Royston D Altman W Sauerbrei, Stat Med 2006 25 127 141 10.1002/sim.2331 16217841
41. Regression modeling of competing crude failure probabilities. JP Fine, Biostatistics 2001 2 85 97 10.1093/biostatistics/2.1.85 12933558
42. A joint model for survival and longitudinal data measured with error. MS Wulfsohn AA Tsiatis, Biometrics 1997 53 330 9 10.2307/2533118 9147598
43. Estimates of clinically useful measures in competing risks survival analysis. F Ambrogi E Biganzoli P Boracchi, Stat Med 2008 27 6407 6425 10.1002/sim.3455 18937229
44. A note on competing risks in survival data analysis. J Satagopan L Ben-Borat M Berwick M Robson D Kutler A Auerbach, Br JCancer 2004 91 1229 1235 10.1038/sj.bjc.6602102 (Pubitemid 39424779)
45. D Spiegelhalter A Thomas N Best W Gilks, WinBUGS User Manual
46. Bayesian measures of model complexity and fit. D Spiegelhalter N Best B Carlin A Van der Linde, JRSS (series B) 2002 64 Part 4 583 639 10.1111/1467-9868.00353
47. SAS macros for estimation of the cumulative incidence functions based on a Cox regression model for competing risks survival data. S Rosthoj PK Andersen SZ Abildstrom, Comput Methods Programs Biomed 2004 74 69 75 10.1016/S0169- 2607(03)00069-5 14992828
48. R Development Core Team, R: A Language and Environment for Statistical Computing R Foundation for Statistical Computing, Vienna, Austria 2008 http://www.R-project.org [ISBN 3-900051-07-0]
49. Assessing surrogacy from the joint modelling of multivariate longitudinal data and survival: application to clinical trial data on chronic lymphocytic leukaemia. E Deslandes S Chevret, Stat Med 2007 26 30 5411 21 10.1002/sim.3142 18058850
50. Survival methods, including those using competing risk analysis, are not appropriate for intensive care unit outcome studies. D Schoenfeld, Crit Care 2006 10 103 10.1186/cc3949 16420653
51. Joint modeling of longitudinal ordinal data and competing risks survival times and analysis of the NINDS rt-PA stroke trial. N Li R Elashoff G Li J Saver, Stat Med 2010 29 5 546 57 19943331
52. Separate and Joint Modeling of Longitudinal and Event Time Data Using Standard Computer Packages. X Guo BP Carlin, Am Stat 2004 58 16 24 10.1198/0003130042854
53. Bayesian methods for joint modeling of longitudinal and survival data with application to cancer vaccine trials. JG Ibrahim M Chen D Sinha, Statistica Sinica 2007 14 863 883
54. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. M Hernan B Brumback J Robins, Epidemiology 2000 11 561 70 10.1097/00001648-200009000-00012 10955409
55. Marginal structural models and causal inference in epidemiology. J Robins M Hernan B Brumback, Epidemiology 2000 11 550 60 10.1097/00001648-200009000- 00011 10955408
56. Latent Class Models for joint Analysis of Longitudinal Biomarker and event process Data: Application to Longitudinal Prostate-Specific Antigen reading and prostate Cancer. H Lin BW Turnbull C McCulloch EH Slate, JASA 2002 97 457 53 65
57. Joint Analysis of Multi-Level Repeated Measures Data and Survival: An Application to the End Stage Renal Disease (Esrd) Data. MJZL Liu J O'Quigley, Stat Med 2008 27 5679 91 10.1002/sim.3392 18693300